Research Impact

h-index

N/A

Research impact score

Publications

0

Total publications

Trial Results

0

Published trial results

Citations

0

Total citations

Drug Portfolio

MIXED(3)
1 unique interventions1 categories

Analytics

Trial Phases

Phase 11
Phase 23

Trial Status

Completed1
Recruiting2

Role Distribution

Principal Investigator3
PI Rate100%

Activity Timeline

Clinical Trials (3)

NCT07364786Phase 2Recruiting
Effect of Salovum® on Pressure, Oxygen and Inflammation in Glioblastoma
Glioblastoma
PrincipalinvestigatorStart date: 2024-10-07
NCT04117672Phase 2Recruiting
Antisecretory Factor In Severe Traumatic Brain Injury
Traumatic Brain Injury
PrincipalinvestigatorStart date: 2020-03-10
NCT04116138Phase 1/2Completed
Antisecretory Factor in Primary Glioblastoma 1
Cerebral EdemaChemotherapy EffectGlioblastoma
PrincipalinvestigatorStart date: 2019-09-01

Research Network

Collaboration Network

1 collaborators·0 connections
Network Legend
KOL
Current Investigator
CO
High-influence Collaborator
CO
Collaborator
Click: view details
Double-click: go to profile
Drag: move node

Research Areas & Affiliations

Affiliations

Skane University Hospital

Similar Key Opinion Leaders

Publications (0)

No publications found for this investigator.

Clinical Trials (3)

Showing 3 of 3 trials

NCT07364786Phase 2PrincipalInvestigator

Effect of Salovum® on Pressure, Oxygen and Inflammation in Glioblastoma

Glioblastoma
Recruiting
NCT04117672Phase 2PrincipalInvestigator

Antisecretory Factor In Severe Traumatic Brain Injury

Traumatic Brain Injury
Recruiting
NCT04116138Phase 1/2PrincipalInvestigator

Antisecretory Factor in Primary Glioblastoma 1

Cerebral EdemaChemotherapy EffectGlioblastoma
Completed

All 3 trials loaded